Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception

被引:253
作者
Nelson, Scott M. [1 ,2 ]
Yates, Robin W. [2 ]
Lyall, Helen [2 ]
Jamieson, Maybeth [2 ]
Traynor, Isabel [2 ]
Gaudoin, Marco [3 ]
Mitchell, Paul [3 ]
Ambrose, Pat [3 ]
Fleming, Richard [1 ,3 ]
机构
[1] Univ Glasgow, Fac Med, Sect Reprod & Maternal Med, Glasgow G31 2ER, Lanark, Scotland
[2] Glasgow Royal Infirm, Assisted Concept Unit, Glasgow G4 0SF, Lanark, Scotland
[3] Glasgow Ctr Reprod Med, Glasgow G51 4FD, Lanark, Scotland
关键词
anti-Mullerian hormone; GNRH AG; ANTAG; ovarian stimulation; IN-VITRO FERTILIZATION; MODIFIED NATURAL CYCLE; HYPERSTIMULATION SYNDROME; TREATMENT STRATEGY; PREDICTIVE FACTORS; TECHNOLOGY CYCLES; MENSTRUAL-CYCLE; POOR RESPONDERS; LIVE BIRTH; IVF;
D O I
10.1093/humrep/den480
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Individualization of controlled ovarian stimulation (COS) for assisted conception is complicated by variable ovarian response to follicle stimulating hormone. We hypothesized that anti-Mullerian hormone (AMH), a predictor of oocyte yield, may facilitate treatment strategies for women undergoing COS, to optimize safety and clinical pregnancy rates. Prospective cohort study of 538 patients in two centres with differential COS strategies based on a centralized AMH measurement. AMH was associated with oocyte yield after ovarian stimulation in both centres, and a 'reduced' AMH (1 to < 5 pmol/l) was associated with a reduced clinical pregnancy rate. Women with a 'normal' AMH (5 to < 15 pmol/l) treated with a long GnRH-agonist protocol (both centres) showed a low incidence of excess response (0%) and poor response (0%). In women with 'high' AMH (> 15 pmol/l), the antagonist protocol eliminated the need for complete cryopreservation of embryos due to excess response (P < 0.001) and showed a higher fresh cycle clinical pregnancy rate than agonist cycles [OR 4.40 (95% CI 1.95-9.93), P < 0.001]. The use of circulating AMH to individualize treatment strategies for COS may result in reduced clinical risk, optimized treatment burden and maintained pregnancy rates, and is worthy of prospective randomized examination.
引用
收藏
页码:867 / 875
页数:9
相关论文
共 33 条
[1]   GnRH antagonist in assisted reproduction: a Cochrane review [J].
Al-Inany, H ;
Aboulghar, M .
HUMAN REPRODUCTION, 2002, 17 (04) :874-885
[2]  
Al-Inany H.G., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001750.PUB2
[3]   A systematic review of tests predicting ovarian reserve and IVF outcome [J].
Broekmans, F. J. ;
Kwee, J. ;
Hendriks, D. J. ;
Mol, B. W. ;
Lambalk, C. B. .
HUMAN REPRODUCTION UPDATE, 2006, 12 (06) :685-718
[4]  
CHANG SY, 1993, FERTIL STERIL, V59, P183
[5]   Serum mullerian-inhibiting substance levels during normal menstrual cycles [J].
Cook, CL ;
Siow, Y ;
Taylor, S ;
Fallat, ME .
FERTILITY AND STERILITY, 2000, 73 (04) :859-861
[6]   The psychological impact more cycles of IVF with a treatment strategy of IVF failure after two or mild versus standard [J].
de Klerk, C. ;
Macklon, N. S. ;
Heijnen, E. M. E. W. ;
Eijkemans, M. J. C. ;
Fauser, B. C. J. M. ;
Passchier, J. ;
Hunfeld, J. A. M. .
HUMAN REPRODUCTION, 2007, 22 (09) :2554-2558
[7]   Follicle dynamics during ovarian ageing [J].
Faddy, MJ .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 163 (1-2) :43-48
[8]   Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation [J].
Fauser, B. C. J. M. ;
Diedrich, K. ;
Devroey, P. .
HUMAN REPRODUCTION UPDATE, 2008, 14 (01) :1-14
[9]   Economic evaluations of single- versus double-embryo transfer in IVF [J].
Fiddelers, A. A. A. ;
Severens, J. L. ;
Dirksen, C. D. ;
Dumoulin, J. C. M. ;
Land, J. A. ;
Evers, J. L. H. .
HUMAN REPRODUCTION UPDATE, 2007, 13 (01) :5-13
[10]   A NEW SYSTEMATIC TREATMENT FOR INFERTILE WOMEN WITH ABNORMAL HORMONE PROFILES [J].
FLEMING, R ;
ADAM, AH ;
BARLOW, DH ;
BLACK, WP ;
MACNAUGHTON, MC ;
COUTTS, JRT .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1982, 89 (01) :80-83